Debates between Baroness Manzoor and Baroness Bakewell during the 2017-2019 Parliament

Breast Cancer: Women Over 73

Debate between Baroness Manzoor and Baroness Bakewell
Tuesday 15th January 2019

(5 years, 10 months ago)

Lords Chamber
Read Full debate Read Hansard Text
Baroness Bakewell Portrait Baroness Bakewell
- Hansard - - - Excerpts

To ask Her Majesty's Government what plans they have to extend the reminder for breast cancer checks to women over 73 years old.

Baroness Manzoor Portrait Baroness Manzoor (Con)
- Hansard - -

My Lords, routine breast screening is currently offered to women aged 50 to 70 on the basis of evidence. There is currently no evidence to suggest that inviting women over 73 for routine screening provides more benefits than harms. However, women over 70 are invited to self-refer for a mammogram every three years if they wish. They are informed of this when they attend their last routine breast screening appointment.

Baroness Bakewell Portrait Baroness Bakewell (Lab)
- Hansard - - - Excerpts

I thank the Minister for that Answer. The risk of breast cancer increases with age. A third of all breast cancers and a quarter of all breast deaths occur in women over 70—I have these figures from Breast Cancer Care, of which I am a patron. Older women need to know and report their symptoms. They need to be reminded, because as you get older your memory fades. Why are the reminders stopped at 70? Although there is now a trial, it stops at the age of 73. What about those of us over 73?

Baroness Manzoor Portrait Baroness Manzoor
- Hansard - -

My Lords, the noble Baroness makes a very interesting point but the NHS breast screening policy is based on strong peer-reviewed evidence. The decision to offer routine screening to women between the ages of 50 and 70 followed support from the Marmot review, which estimated that inviting women between the ages of 50 and 70 reduces mortality from breast cancer in the population invited by 20% and saves an estimated 1,300 lives a year. It also stated that evidence to support screening outside the 50 to 70 age group was not strong enough to allow older women to be invited for screening routinely.